Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt. | 11 | - |
| 2 | Schedule 2 | Not yet disclosed by govt. | 11 | - |
| 3 | Schedule 3 | Not yet disclosed by govt. | 11 | - |
| 4 | Schedule 4 | Not yet disclosed by govt. | 11 | - |
| 5 | Schedule 5 | PHARMA (INDIA) | 3 | ₹16,800 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
12 May 2026, 2:00 pmClosed
IMATINIB MESYLATE 100 MG CAP
RANITIDINE HCL 50 MG 2 ML INJ
VECURONIUM BROMIDE 4 MG PER ML 1 ML INJ
GLYCOPYRROLATE 0 POINT 2 MG PER ML 1 ML INJ
MISOPROSTOL 200 MCG TAB
9212370
GEM/2026/B/7434983
Two Packet Bid
IMATINIB MESYLATE 100 MG CAP,RANITIDINE HCL 50 MG 2 ML INJ,VECURONIUM BROMIDE 4 MG PER ML 1 ML INJ,
Mumbai, Maharashtra
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹1 L
₹1 L
20%
Exempted
Yes
12 May 2026
2 May 2026
12 May 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | IMATINIB MESYLATE 100 MG CAP | 3,400 | NO | Mumbai | 30 |
| 2 | RANITIDINE HCL 50 MG 2 ML INJ | 5,160 | AMP | Mumbai | 30 |
| 3 | VECURONIUM BROMIDE 4 MG PER ML 1 ML INJ | 3,000 | AMP | Mumbai | 30 |
| 4 | GLYCOPYRROLATE 0 POINT 2 MG PER ML 1 ML INJ | 4,500 | AMP | Mumbai | 30 |
| 5 | MISOPROSTOL 200 MCG TAB | 4,200 | TAB | Mumbai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9212370.pdf
GEM_BID • 0.13 MB
bbqr_imitanib_2026-04-11-08-59-24_190e5695357fc82e6050d2dd112c85c1.pdf
BOQ • 0.22 MB
imatinib_boq_2026-04-11-08-59-24_c1116ff1c13da54c4047874ba011b4f0.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .